单核细胞与高密度脂蛋白胆固醇比值在动脉粥样硬化性疾病中的研究进展

doi:10.3969/j.issn.1004-583X.2022.10.014

摘要/Abstract

摘要：

动脉粥样硬化是动脉血管壁发生纤维脂肪病变,引起斑块形成的慢性炎症过程,是导致心肌梗死、缺血性脑卒中等心脑血管疾病发生的病理基础。单核细胞是人体内常见的免疫细胞;高密度脂蛋白胆固醇在体内对动脉粥样硬化具有保护作用。单核细胞与高密度脂蛋白胆固醇比值(monocytes-to-HDL cholesterol ratio, MHR)是一种新的炎症性指标,本文就MHR的定义及其与动脉粥样硬化性疾病的关系进行综述,以期为临床诊治动脉粥样硬化性疾病提供一种新的生物学标志物。

关键词: 动脉粥样硬化, 单核细胞, 高密度脂蛋白胆固醇, 单核细胞与高密度脂蛋白胆固醇比值

中图分类号:

R543.5

贺容容, 李锦霞, 任俊豪, 孙辉. 单核细胞与高密度脂蛋白胆固醇比值在动脉粥样硬化性疾病中的研究进展[J]. 临床荟萃, 2022, 37(10): 950-952.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2022.10.014

https://huicui.hebmu.edu.cn/CN/Y2022/V37/I10/950

参考文献 25

[1]	Curi R, de Siqueira Mendes R, de Campos Crispin LA, et al. A past and present overview of macrophage metabolism and functional outcomes[J]. Clin Sci (Lond), 2017, 131(12):1329-1342. doi: 10.1042/CS20170220 pmid: 28592702
[2]	Kundi H, Kiziltunc E, Cetin M, et al. Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease[J]. Herz, 2016, 41(6):523-529. doi: 10.1007/s00059-015-4393-1 pmid: 26753671
[3]	Yang J, Zhang L, Yu C, et al. Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases[J]. Biomark Res, 2014, 2(1):1. doi: 10.1186/2050-7771-2-1 pmid: 24398220
[4]	Kim KW, Ivanov S, Williams JW. Monocyte recruitment, specification, and function in atherosclerosis[J]. Cells, 2020, 10(1):15. doi: 10.3390/cells10010015 URL
[5]	Nozawa N, Hibi K, Endo M, et al. Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction[J]. Circ J, 2010, 74(7):1384-1391. pmid: 20467155
[6]	Jaipersad AS, Lip GY, Silverman S, et al. The role of monocytes in angiogenesis and atherosclerosis[J]. J Am Coll Cardiol, 2014, 63(1):1-11. doi: 10.1016/j.jacc.2013.09.019 pmid: 24140662
[7]	Ossoli A, Remaley AT, Vaisman B, et al. Plasma-derived and synthetic high-density lipoprotein inhibit tissue factor in endothelial cells and monocytes[J]. Biochem J, 2016, 473(2):211-219. doi: 10.1042/BJ20151000 pmid: 26556891
[8]	Usta A, Avci E, Bulbul CB, et al. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome[J]. Reprod Biol Endocrinol, 2018, 16(1):34. doi: 10.1186/s12958-018-0351-0 URL
[9]	Kontush A, Lindahl M, Lhomme M, et al. Structure of HDL: Particle subclasses and molecular components[J]. Handb Exp Pharmacol, 2015, 224:3-51. doi: 10.1007/978-3-319-09665-0_1 pmid: 25522985
[10]	Calabresi L, Gomaraschi M, Franceschini G. High-density lipoprotein quantity or quality for cardiovascular prevention?[J]. Curr Pharm Des, 2010, 16(13):1494-1503. doi: 10.2174/138161210791050960 URL
[11]	Ganjali S, Momtazi AA, Banach M, et al. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions[J]. Prog Lipid Res, 2017, 67:16-26. doi: S0163-7827(17)30011-5 pmid: 28506805
[12]	Acikgoz N, Kurtoˇglu E, Yagmur J, et al. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in behçet disease[J]. Angiology, 2018, 69(1):65-70. doi: 10.1177/0003319717704748 pmid: 28421814
[13]	Murphy AJ, Akhtari M, Tolani S, et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice[J]. J Clin Invest, 2011, 121(10):4138-4149. doi: 10.1172/JCI57559 URL
[14]	Bolayir A, Gokce SF, Cigdem B, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients[J]. Neurol Neurochir Pol, 2018, 52(2):150-155. doi: S0028-3843(17)30104-4 pmid: 28864326
[15]	Kadihasanoglu M, Karabay E, Yucetas U, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio and presence and severity of erectile dysfunction[J]. Aktuelle Urol, 2018, 49(3):256-261. doi: 10.1055/s-0042-123163 URL
[16]	You S, Zhong C, Zheng D, et al. Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patients with acute intracerebral hemorrhage[J]. J Neurol Sci, 2017, 372:157-161. doi: S0022-510X(16)30717-1 pmid: 28017204
[17]	Canpolat U, Çetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation[J]. Clin Appl Thromb Hemost, 2016, 22(5):476-482. doi: 10.1177/1076029615594002 URL
[18]	Ganjali S, Gotto AM Jr, Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases[J]. J Cell Physiol, 2018, 233(12):9237-9246. doi: 10.1002/jcp.27028 pmid: 30076716
[19]	Akboga MK, Yayla C, Balci KG, et al. Relationship between serum albumin level and monocyte-to-high-density lipoprotein cholesterol ratio with saphenous vein graft disease in coronary bypass[J]. Thorac Cardiovasc Surg, 2017, 65(4):315-321. doi: 10.1055/s-0036-1582260 pmid: 27111497
[20]	黄朝发, 李菊香, 颜素娟, 等. 单核细胞/高密度脂蛋白胆固醇比值与急性心肌梗死患者介入术后慢血流或无复流的相关性分析[J]. 中国循环杂志, 2017, 32(8):737-741.
[21]	Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome[J]. Heart Lung Circ, 2016, 25(11):1077-1086. doi: S1443-9506(16)30047-6 pmid: 27118231
[22]	陈洁霞, 李结华, 唐海沁. 单核细胞与高密度脂蛋白比值和颈动脉粥样硬化斑块稳定性的相关性研究[J]. 中国临床保健杂志, 2017, 20(4):383-385.
[23]	Wang HY, Shi WR, Yi X, et al. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: Insights from a population-based Chinese cohort[J]. Lipids Health Dis, 2019, 18(1):127. doi: 10.1186/s12944-019-1076-6 URL
[24]	Li Y, Chen D, Sun L, et al. Monocyte/high-density lipoprotein ratio predicts the prognosis of large artery atherosclerosis ischemic stroke[J]. Front Neurol, 2021, 12:769217. doi: 10.3389/fneur.2021.769217 URL
[25]	Liu Z, Fan Q, Wu S, et al. Associations of monocytes and the monocyte/high-density lipoprotein ratio with extracranial and intracranial atherosclerotic stenosis[J]. Front Neurol, 2021, 12:756496. doi: 10.3389/fneur.2021.756496 URL

单核细胞与高密度脂蛋白胆固醇比值在动脉粥样硬化性疾病中的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 15

编辑推荐

Metrics

本文评价

[1]	黄宇玲, 张欣悦, 荣萍萍, 杨文琦, 曹新营, 邢彩耐, 王志军, 刘宁. Non-HDL-C/HDL-C和NHR与冠状动脉病变严重程度的相关性[J]. 临床荟萃, 2024, 39(2): 115-120.
[2]	魏宇涵, 赵亚楠, 张桂彬, 吴雨晴, 董博华, 扈家源, 杨文琦. 单核细胞/高密度脂蛋白胆固醇比值、红细胞分布宽度、尿酸与冠心病患者冠状动脉病变严重程度的相关性[J]. 临床荟萃, 2023, 38(9): 796-801.
[3]	肖梦, 程婷婷, 马倩格, 冯晓颖, 李利华, 李涛. 承德地区EB病毒感染和传染性单核细胞增多症患儿临床特点[J]. 临床荟萃, 2023, 38(6): 526-531.
[4]	聂芳, 罗俊. 成都地区传染性单核细胞增多症患儿早期危险指标分析[J]. 临床荟萃, 2023, 38(11): 1008-1011.
[5]	徐阳, 薛凌. H型高血压合并2型糖尿病患者轻度认知功能障碍的影响因素[J]. 临床荟萃, 2023, 38(10): 887-892.
[6]	张怡, 崔晓冉, 杨晓红. 单核细胞/高密度脂蛋白胆固醇比值在心血管疾病中研究进展[J]. 临床荟萃, 2022, 37(6): 551-555.
[7]	张磊, 娄海东, 智昱, 亓树莹. PCSK9抑制剂对动脉粥样硬化性心血管疾病有效性及安全性的meta分析[J]. 临床荟萃, 2022, 37(12): 1074-1080.
[8]	张雪晴, 陈树春. 血尿酸与高密度脂蛋白胆固醇比值在糖脂代谢相关疾病中的研究进展[J]. 临床荟萃, 2022, 37(11): 1044-1047.
[9]	文洁. 血浆致动脉粥样硬化指数与非酒精性脂肪性肝病的相关性[J]. 临床荟萃, 2022, 37(1): 35-38.
[10]	刘宇博, 冯平勇, 杨海骁, 孙婕, 张天资. 高分辨磁共振血管壁成像在颅内动脉粥样硬化性缺血性卒中的研究进展[J]. 临床荟萃, 2021, 36(12): 1148-1152.
[11]	王超, 万多, 李卅立, 王曦. 颈动脉多普勒超声对慢性肾病患者动脉粥样硬化程度及血流动力学的评估价值[J]. 临床荟萃, 2021, 36(11): 1009-1012.
[12]	陈隽, 周一薇, 李秀娟. 症状性下肢动脉疾病抗栓治疗分析[J]. 临床荟萃, 2021, 36(10): 937-941.
[13]	尚启航, 陈华茜. 维持性血液透析患者嗜酸性粒细胞水平与颈动脉粥样硬化的关系[J]. 临床荟萃, 2021, 36(1): 44-48.
[14]	王红梅，张婷，陈静炯，邓江山，徐周伟，付剑亮，赵玉武. 低T3水平与大动脉粥样硬化型脑梗死患者短期预后的关系[J]. 临床荟萃, 2020, 35(6): 517-520.
[15]	陈先睿，黄建琪，郭碧赟，温红，白海涛，许锦平. 以颅内静脉窦血栓为首发表现的急性单核细胞白血病1例报告并文献复习[J]. 临床荟萃, 2020, 35(1): 76-79.